Old Web
English
Sign In
Acemap
>
authorDetail
>
J de Vries-van der Weij
J de Vries-van der Weij
Internal medicine
Endocrinology
Diabetes mellitus
Medicine
Cardiology
4
Papers
63
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Abstract: 533 BEXAROTENE INDUCES DYSLIPIDEMIA BY INCREASED VLDL PRODUCTION AND CETP-MEDIATED REDUCTION OF HDL
2009
Atherosclerosis Supplements
J de Vries-van der Weij
W. De Haan
Lihui Hu
J van der Hoorn
L.M. Havekes
H.M.G. Princen
J.A. Romijn
J.W.A. Smit
P.C.N. Rensen
Show All
Source
Cite
Save
Citations (0)
BEXAROTENE INDUCES DYSLIPIDEMIA BY INCREASED VLDL PRODUCTION AND CETP-MEDIATED REDUCTION OF HDL
2009
Atherosclerosis Supplements
J de Vries-van der Weij
Willeke de Haan
Lihui Hu
J van der Hoorn
L.M. Havekes
H.M.G. Princen
J.A. Romijn
J.W.A. Smit
P.C.N. Rensen
Show All
Source
Cite
Save
Citations (0)
Abstract: 142 HUMAN CETP AGGREVATES ATHEROSCLEROSIS BY INCREASING VLDL-CHOLESTEROL RATHER THAN BY DECREASING HDLCHOLESTEROL IN APOE*3-LEIDEN MICE
2009
Atherosclerosis Supplements
J de Vries-van der Weij
Karin Toet
Susanne Zadelaar
L.M. Havekes
T. Kooistra
Pcn Rensen
Show All
Source
Cite
Save
Citations (3)
Fenofibrate Reduces Atherogenesis in ApoE*3Leiden Mice: Evidence for Multiple Antiatherogenic Effects Besides Lowering Plasma Cholesterol
2006
Arteriosclerosis, Thrombosis, and Vascular Biology
T. Kooistra
Lars Verschuren
J de Vries-van der Weij
Wolfgang Koenig
Karin Toet
H.M.G. Princen
Robert Kleemann
Show All
Source
Cite
Save
Citations (60)
1